Welcome

Sign out Have a question? We're here to help

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Bausch Health Companies Inc (BHC)

$28.40 0.79 (2.71%)

19:49 EST BHC Stock Quote Delayed 15 Minutes

Volume:

Previous Close $28.40

Market Cap -

PE Ratio -10.76

EPS -2.64

Volume (Avg. Vol.) 4.81M

Day's Range 28.13 - 29.31

52-Week Range 18.72 - 31.97

Dividend & Yield N/A (N/A)

BHC Stock Predictions, Articles, and Bausch Health Companies Inc News

From InvestorPlace
From the Web

4 Top Stock Trades for Tuesday: MCD, UAA, Berkshire

By Bret Kenwell, InvestorPlace Contributor Nov 4, 2019

Berkshire Hathaway, McDonald's, Under Armour and Bausch Health were our top stock trades from Monday. Here's a look at the charts.

10 Healthcare Stocks to Buy Despite the Headlines

By James Brumley, InvestorPlace Feature Writer Sep 10, 2019

Eli Lilly, Alexion and AbbVie are just some of the top healthcare stocks to buy here, now that disappointing news has driven them to cheap prices.

Stock Market Today: How Many Times Will the Fed Cut Rates?

By Bret Kenwell, InvestorPlace Contributor Aug 6, 2019

After six straight sessions of losses, it was a welcomed sight to see stocks rally on Tuesday. Here's what happened on the stock market today.

10 Stocks to Buy That Wall Street Expects to Soar for the Rest of 2019

By Vince Martin, InvestorPlace Contributor Jun 13, 2019

Wall Street analysts see significant upside in these 10 stocks to buy. And all ten have other reasons for optimism as well.

9 U.S. Stocks That Are Coming to Life Again

By James Brumley, InvestorPlace Feature Writer Feb 12, 2019

All-American U.S. stocks like Foot Locker, Copart and Snapchat are on the mend for all the right reasons. here are the charts to watch.

All Signals Are Positive for Buying Abbott Laboratories

By Chris Lau, InvestorPlace Contributor Jan 22, 2019

Abbott is about to report another quarter to cap 2018's strong annual performance. ABT stock also offers a dividend for income investors.

Compare Brokers

Even Following the Latest Surge, Mylan Stock Has Plenty of Room to Grow

By Chris Lau, InvestorPlace Contributor Nov 8, 2018

Mylan stock jumped ahead following quarterly earnings that impressed investors. Management will continue doing better than expected.

7 Rising Healthcare Stocks to Consider

By Chris Lau, InvestorPlace Contributor Oct 29, 2018

Healthcare stocks recovered throughout 2018 but the recent correction in some big names is creating an entry point.

16 Stocks to Buy Before They Turn It Around

By Vince Martin, InvestorPlace Contributor Oct 11, 2018

GE stock is just one of the many turnaround stocks in the market. These 16 equities all could be stocks to buy - if execution improves.

5 Hot Stocks Today (That Could Crash Tomorrow)

By Bret Kenwell, InvestorPlace Contributor Jul 19, 2018

There are always hot stocks in the market but that doesn't mean investors should always buy -- they could be bull traps in the making.

Bausch Health Companies (BHC) Receives a Buy from Barclays

From Analyst Ratings Jan 27, 2020

In a report issued on January 24, Balaji Prasad from Barclays maintained a Buy rating on Bausch Health Companies (BHC – Research Report), with a price target of $33.00. The company’s shares closed last Monday at $28.40. According to TipRanks.com, Prasad is a 4-star analyst with an average return of 16.6% and a 70.0% success

Revance, Amphastar Named Top 2020 Specialty Pharmaceuticals Ideas At Wells Fargo

From Talk Markets Jan 22, 2020

Wells Fargo analyst Jacob Hughes named Revance Therapeutics and Amphastar Pharmaceuticals his top ideas for 2020 in the Specialty Pharmaceuticals space.

Bausch Health to drop Cipher's Trulance

From Seeking Alpha Jan 21, 2020

Cipher Pharmaceuticals (OTC:CPHRF) reports that Bausch Health Companies (NYSE:BHC) has notified it that it intends to terminate its license agreement for constipation med Trulance (plecanatide) due to

Cipher Pharma receives termination notice from Bausch Health

From Seeking Alpha Jan 21, 2020

Cipher Pharmaceuticals (OTC:CPHRF) has received a Notice of Termination from Bausch Health (NYSE:BHC) in connection with the License, Development and Commercialization Agreement of Trulance® (plecana

Ocugen Stock Might be up 34% in 2020 but There are Other Eye Care Plays

From InvestorPlace Jan 21, 2020

Except for a couple of specific investors, Ocugen stock is not one for average people. Instead, look at Bausch Health Companies, which has a very rocky backstory but has managed to turn the corner.

Best & Worst Performing Large Cap Stocks for January 20, 2020

From StockNews.com Jan 20, 2020

SNAP – SNAP leads the way today as the best performing large cap stock, closing up 4.71%.

Navellier Ratings

Powered by Portfolio Grader

Total Grade

C

Hold